doi: 10.1124/jpet.118.254821 63 TonneijckL.MuskietM
Research suggests that AMP-activated protein kinase (AMPK) plays a crucial role in doxorubicin-induced cardiotoxicity
ACS Nano 7 , 30363044 (2013)
Myth #8: Insurance Denial Means You Cant Afford Treatment The Claim: My insurance denied coverage so I guess I just cant lose weight, these drugs cost $15,000 a year (Multiple forum posts) The Reality: Insurance denial is frustrating but doesnt eliminate all options
[13] [14] In 2023, it was the 209th most commonly prescribed medication in the United States, with more than 2 million prescriptions
Approved uses are not interchangeable Across the class, FDA-approved indications include type 2 diabetes for most compounds, chronic weight management for Wegovy, Saxenda, and Zepbound, cardiovascular risk reduction in type 2 diabetes for several products, and obstructive sleep apnea in adults with obesity for Zepbound as of 2024